Latest Lead News

Rhythm Biosciences has completed the first commercial sale of its ColoSTAT® blood test for colorectal cancer, confirming the full clinical and logistical process is operational and ready for expansion.

NuEnergy Gas Limited has completed four wells under its Tanjung Enim Early Gas Sales Initiative, secured a binding gas sales agreement, and raised $3.5 million to advance its Indonesian coal bed methane projects.

QPM Energy Limited has announced a substantial upgrade to its Moranbah Gas Project reserves and resources, now certified at over 1,000 petajoules, positioning the company as a key player in Queensland’s evolving gas and electricity markets.

NH3 Clean Energy has received multiple engineering proposals for the Front End Engineering and Design (FEED) of its WAH2 clean ammonia project and commenced a detailed flora survey, marking significant progress toward its Final Investment Decision by year-end.

Strata Minerals is set to restart drilling at its Zelica Gold Project, aiming to expand high-grade gold zones and fast-track a maiden resource estimate. The project corridor now extends over 8km following a recent acquisition.

Western Gold Resources has locked in critical approvals and agreements to accelerate production at its Gold Duke Project in Western Australia, backed by an updated resource estimate and a binding toll milling contract.

DPM Metals has lodged a detailed technical report updating the Mineral Resource and Reserve estimates for its Chelopech mine in Bulgaria, underpinning its strategic growth plans.

St George Mining has appointed Carla Grasso as Principal Geologist to spearhead mine planning at its Araxá Rare Earths-Niobium Project, following a major resource upgrade. This move signals a decisive step towards advancing economic studies and potential mining operations in Brazil.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Clarity Pharmaceuticals has completed enrolment in its Phase III AMPLIFY trial for the Cu-SAR-bisPSMA imaging agent, advancing its bid for FDA approval in prostate cancer diagnostics.

ABx Group has discovered new high-extraction ionic rare earth zones at its Deep Leads project in Tasmania, accelerating the path to production within months of approval. This breakthrough enhances the project's commercial viability with rare earths critical for green technologies.

Viridis Mining’s Colossus Rare Earth Project has been selected for Brazil’s Climate and Ecological Transformation Investment Platform, enhancing its access to international capital ahead of a key investment decision.